We are live on ! Find out more
WVP

Worth Venture Partners Portfolio holdings

AUM $31.6M
1-Year Est. Return 28.5%
This Fund
S&P 500
This Quarter Est. Return
+1.67%
1 Year Est. Return
+28.5%
3 Year Est. Return
+102.5%
5 Year Est. Return
+128.77%
10 Year Est. Return
AUM
$163M
AUM Growth
-$6.83M
Cap. Flow
-$37.1M
Cap. Flow %
-22.75%
Top 10 Hldgs %
30.94%
Holding
192
New
47
Increased
35
Reduced
23
Closed
17

Sector Composition

Rank Sector Weight
1 Technology 23.41%
2 Healthcare 15.13%
3 Consumer Discretionary 5.61%
4 Financials 5.45%
5 Materials 2.94%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ARDX icon
51
Ardelyx
ARDX
$1.24B
$433K 0.27%
364,102
-567,847
-61% -$540K
XFOR icon
52
X4 Pharmaceuticals
XFOR
$377M
$428K 0.26%
8,338
EOLS icon
53
Evolus
EOLS
$395M
$403K 0.25%
+50,030
New +$530K
APPS icon
54
Digital Turbine
APPS
$1.03B
$397K 0.24%
27,518
+1,346
+5% +$25.7K
CGRN
55
DELISTED
Capstone Green Energy Corporation Common Stock
CGRN
$396K 0.24%
+223,920
New +$518K
MCHP icon
56
Microchip Technology
MCHP
$40.4B
$395K 0.24%
6,473
+470
+8% +$30.9K
RVLP
57
DELISTED
RVL Pharmaceuticals plc Ordinary Shares
RVLP
$390K 0.24%
+185,647
New +$361K
CGTX icon
58
Cognition Therapeutics
CGTX
$80.1M
$380K 0.23%
200,188
-27,982
-12% -$58.3K
IRT icon
59
Independence Realty Trust
IRT
$3.94B
$364K 0.22%
+21,743
New +$440K
CNTX icon
60
Context Therapeutics
CNTX
$56.8M
$358K 0.22%
322,628
+25,016
+8% +$45K
RNAZ icon
61
TransCode Therapeutics
RNAZ
$4.81M
0
SDS icon
62
ProShares UltraShort S&P500
SDS
$408M
$327K 0.2%
1,200
TYL icon
63
Tyler Technologies
TYL
$12.7B
$303K 0.19%
871
+201
+30% +$74.8K
FKWL icon
64
Franklin Wireless
FKWL
$27M
$289K 0.18%
98,826
TOL icon
65
Toll Brothers
TOL
$13.9B
$286K 0.18%
+6,800
New +$315K
ADVM
66
DELISTED
Adverum Biotechnologies
ADVM
$284K 0.17%
29,856
+4,976
+20% +$65.4K
MTN icon
67
Vail Resorts
MTN
$5.43B
$267K 0.16%
1,238
EQC
68
DELISTED
Equity Commonwealth
EQC
$257K 0.16%
10,553
SPG icon
69
Simon Property Group
SPG
$74.1B
$256K 0.16%
2,850
+650
+30% +$66.5K
KRG icon
70
Kite Realty
KRG
$5.75B
$255K 0.16%
14,800
VCNX
71
DELISTED
Vaccinex, Inc. Common Stock
VCNX
$251K 0.15%
2,418
MYO icon
72
Myomo
MYO
$41.3M
$249K 0.15%
153,936
TCDA
73
DELISTED
Tricida, Inc. Common Stock
TCDA
$249K 0.15%
23,800
ALCO icon
74
Alico
ALCO
$283M
$230K 0.14%
8,138
+700
+9% +$23.6K
TBX icon
75
ProShares Short 7-10 Year Treasury
TBX
$20.9M
$229K 0.14%
+8,000
New +$217K

Similar funds

Worth Venture Partners's Q3 2022 Portfolio in Review

As of Q3 2022, Worth Venture Partners held 192 positions worth $163M, down 4% from $170M the previous quarter. Its ten largest holdings account for 31% of the portfolio.

Worth Venture Partners withdrew a net $37.1M in Q3 2022, closing 17 positions and reducing 23 holdings. Its most notable exit was Cyberoptics Corp, an estimated $3.74M position sold in full.

By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 17% a quarter earlier, followed by Healthcare and Consumer Discretionary.

Against the trend, Worth Venture Partners opened a new position in Adtran worth $5.8M.

  • Worth Venture Partners's largest Q3 2022 buy was Adtran: 296,241 shares worth $5.8M.
  • Worth Venture Partners added most to TELA Bio in Q3 2022, an estimated $2.22M increase.
  • Worth Venture Partners's biggest Q3 2022 reduction was CTO Realty Growth, cutting an estimated $865K.
  • Worth Venture Partners fully exited Cyberoptics Corp in Q3 2022, selling an estimated $3.74M.
  • Worth Venture Partners's ten largest holdings make up 31% of its $163M portfolio in Q3 2022.
  • Worth Venture Partners opened 47 new positions and closed 17 in Q3 2022.
  • Worth Venture Partners's portfolio value fell 4% quarter-over-quarter to $163M.

Based on Worth Venture Partners's 13F filing for Q3 2022, filed 14 Nov 2022.